A world-first clinical trial to treat people with problem methamphetamine, or 'ice', use is recruiting participants from Port Stephens and the Hunter.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
The LiMA (lisdexamfetamine for the treatment of methamphetamine dependence) study is testing if a high dosage of lisdexamfetamine - an existing drug approved to treat Attention Deficit Hyperactivity Disorder - is effective in reducing methamphetamine use, cravings and withdrawal symptoms.
"Australia has one of the highest rates of methamphetamine use in the world," said Professor Adrian Dunlop from Hunter New England Health.
"We've consistently seen methamphetamine users presenting for treatment over the past decade across this region. While counselling is effective for some, we currently don't have a proven medication treatment for severe methamphetamine dependence."
The LiMA study has recruited 142 people to date and is looking for 38 more.
Recruitment is via specialist Drug and Alcohol treatment centres and participants will receive counselling.
Contact HNE Health Drug and Alcohol Clinical Services on 0417 656 352 or visit www.limastudy.info.
